Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis

Oncogene

Volumn 13, Issue 1, 1996, Pages 55-61

  Wallace, Helen ^a,b   Clarke, Alan R ^a   Harrison, David J ^a   Hooper, Martin L ^a   Bishop, John O ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Herpes simplex virus; p53; Thymidine kinase; Transgenic mice

Indexed keywords

GANCICLOVIR; GANCICLOVIR DERIVATIVE; PROTEIN P53; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; GENE SEQUENCE; HERPES SIMPLEX VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; THYROID CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CATTLE; CELL DIVISION; DNA; DNA REPLICATION; DNA, MITOCHONDRIAL; ENZYME INDUCTION; FEMALE; GANCICLOVIR; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; SIMPLEXVIRUS; THYMIDINE KINASE; THYROGLOBULIN; THYROID GLAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029977047     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bellamy CO, Malcomson RG, Harrison DJ and Wyllie AH. (1995). Seminars in Cancer Biology, 6, 3-16.
2. Burton K. (1967). Methods Enzymol., 8, 162-166.
3. Cheng YC, Huang ES, Lin JC, Mar EC, Pagano JS, Dutschman GE and Grill SP. (1983). Proc. Natl. Acad. Sci. USA, 80, 2767-2770.
4. Church GM and Gilbert W. (1984). Proc. Natl. Acad. Sci. USA, 81, 1991-1995.
5. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature, 362, 849-852.
6. Clarke AR, Gledhill S, Hooper ML, Bird CC and Wyllie AH. (1994). Oncogene, 9, 1767-1773.
7. Clarke AR, Cummings MC and Harrison DJ. (1995). Oncogene, 11, 1913-1920.
8. Colombel M, Olsson CA, Ng PY and Buttyan R. (1992). Cancer Res., 52, 4313-4319.
9. Colombo BM, Benedetti S, Ottolenghi S, Mora M, Polio B, Poli G and Finocchiaro G. (1995). Hum. Gene Ther., 6, 763-772.
10. Culver KW and Blaese RM. (1994). Trends Genet., 10, 174-178.
11. de Martynoff G, Pohl V, Mercken L, van Ommen GJ and Vassart G. (1987). Eur. J. Biochem., 164, 591-599.
12. Farquharson C and Loveridge N. (1990). Bone Miner., 10, 121-130.
13. Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL and Abraham GN. (1993). Cancer Res., 53, 5274-5283.
14. Greenlund LJ, Deckwerth TL and Johnson EM Jr. (1995). Neuron, 14, 303-315.
15. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
16. Howie SE, Sommerfield AJ, Gray E and Harrison DJ. (1994). Clin. Exper. Immunol., 95, 195-200.
17. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC and Raff MC. (1993). Nature, 361, 365-369.
18. Kaneko Y and Tsukamoto A. (1995). Cancer Lett., 96, 105-110.
19. Kato K, Yoshida J, Mizuno M, Sugita K and Emi N. (1994). Neurologia Medico-Chirurgica, 34, 339-344.
20. Mack DH, Vartikar J, Pipas JM and Laimins LA, (1993). Nature, 363, 281-283.
21. Maxam AM and Gilbert W. (1980). Methods Enzymol., 65, 499-560.
22. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP and Hall PA. (1994). Cancer Res., 54, 614-617.
23. Rubnitz J and Subramani S. (1985). Mol. Cell. Biol., 5, 529-537.
24. Samejima Y and Meruelo D. (1995). Gene Therapy, 2, 50-58.
25. Sandstrom PA and Buttke TM. (1993). Proc. Natl. Acad. Sci. USA, 90, 4708-4712.
26. Shivji KK, Kenny MK and Wood RD. (1992). Cell, 69, 367-374.
27. Smeds S and Wollman SH. (1983). Endocrinology, 112, 1718-1722.
28. Smee DF, Martin JC, Verheyden JP and Matthews TR. (1983). Antimicrob. Agents Chemother., 23, 676-682.
29. St Clair MH, Lambe CU and Furman PA. (1987). Antimicrob. Agents Chemother., 31, 844-849.
30. Strasser A, Harris AW, Jacks T and Cory S. (1994). Cell, 79, 329-339.
31. Toschi L and Bravo R. (1988). J. Cell Biol., 107, 1623-1628.
32. Ueda N and Shah SV. (1992). J. Clin. Invest., 90, 2593-2597.
33. Wallace H, Ledent C, Vassart G, Bishop JO and Al-Shawi R. (1991). Endocrinology, 129, 3217-3226.
34. Wallace H, McLaren K, Al-Shawi R and Bishop JO. (1994). J. Endocrinol., 143, 107-120.
35. Wallace H, Pate A and Bishop JO. (1995). J. Endocrinol., 145, 251-262.
36. Warters RL. (1992). Cancer Res., 52, 883-890.
37. Wolvetang EJ, Johnson KL, Krauer K, Ralph SJ and Linnane AW. (1994). FEBS Lett., 339, 40-44.
38. Yonish Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.